Find policies, billing codes, payers, states, and providers
CPT 88371: Western Blot Protein Analysis of Tissue
CPT code 88371 denotes a Western blot protein analysis performed on tissue specimens (commonly muscle tissue), with interpretation and reporting included. This laboratory pathology code is nationally relevant because Western blot testing is a specialized diagnostic technique used in neuromuscular and other tissue-based disease evaluations. Accurate coding affects clinical documentation, lab workflow, and payer adjudication across commercial and federal payers.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides benchmarks for utilization and payment patterns, clarifies clinical context for when tissue Western blotting is used, and summarizes relevant policy considerations affecting coverage and billing practices.
Readers will learn the clinical purpose of CPT code 88371, typical sites of service, common billing modifiers (listed separately), and where to find related laboratory service codes. The document highlights areas where coding clarity matters for laboratory reporting, payer coverage decisions, and downstream clinical interpretation. Data not available in the input are noted where applicable.
Customize your policy alerts
Sign up for cpt 88371 policy alerts
Get alerted when payer policies referencing 88371 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 88371 describes a protein analysis of tissue using the Western blot method, typically performed by a clinical laboratory analyst. The code includes interpretation and a written report of the test findings.
Service type: Laboratory — molecular/protein diagnostic analysis
Typical site of service: Clinical laboratory or hospital pathology laboratory, commonly performed on tissue specimens such as muscle tissue.